This bill bans direct-to-consumer advertising of prescription drugs by pharmaceutical manufacturers. It affects drug companies that currently market medications directly to patients through TV, radio, print, digital platforms, or social media. The prohibition applies to all prescription drugs approved under federal law, regardless of when they were approved, and takes effect 30 days after enactment. The law targets advertising practices without altering drug approval processes or patient access.
HR 4591, the Habitat Enhancement Now Act, creates two federal grant programs to boost waterfowl populations. It provides $3.5 million annually (2026-2030) for grants to states, tribes, nonprofits, or individuals to install nesting structures (like hen houses) in the Prairie Pothole Region to improve duck nest success, and to establish nesting cover, brood ponds, and incentivize private landowners in California to enhance breeding habitat for mallards and gadwalls. The bill directly affects landowners who participate in the California program and conservation entities implementing both programs. Key mechanisms include competitive grants for specific habitat actions proven to increase nest success, based on scientific findings about declining duck populations. The funding is explicitly allocated for these targeted habitat management activities.
This bill amends the Family and Medical Leave Act (FMLA) and federal employee leave rules to clarify that recovery from organ donation surgery qualifies as a "serious health condition." It directly affects private-sector workers covered by the FMLA and federal civil service employees. The key change adds "including recovery from surgery related to organ donation" to the definitions of serious health conditions in both the FMLA and federal leave statutes. This ensures eligible employees can use their existing family and medical leave benefits to recover after donating an organ, without requiring new leave entitlements.
HR 4335, the Abraham Accords Defense Against Terror Act, streamlines U.S. defense exports to countries that have normalized relations with Israel (via the Abraham Accords) and cooperate with the U.S. on countering Iran and Iran-aligned threats in the Middle East and North Africa. The bill authorizes the Secretary of State to identify qualifying countries and fast-tracks approval for military sales, leases, or transfers to them, requiring a 15-day congressional notification with specific safeguards. Key safeguards include ensuring sensitive U.S. technology isn’t shared with China or Russia and mandating regular strategy reports to Congress on implementation, threat assessments, and pending defense deals over $25 million. This directly affects participating Middle Eastern nations and U.S. defense export processes, aiming to accelerate security cooperation without altering Israel’s military edge. The bill focuses on procedural changes to expedite defense cooperation, not on new funding or policy outcomes.
HR 1522, the Federal Retirement Fairness Act, changes federal retirement rules to include temporary employees' service after January 1, 1988, in retirement benefit calculations. It directly affects temporary federal employees (including U.S. Postal Service workers) and Members of Congress who served after that date. The bill removes a previous cutoff date in retirement law, allowing their temporary service to count toward retirement eligibility. This means eligible temporary workers can now have their full service period considered when calculating retirement benefits.
HRES 589 requires the U.S. Attorney General to publicly release, within 30 days of enactment, searchable and downloadable documents related to the Jeffrey Epstein investigation - including DOJ communications, case files (like *United States v. Maxwell*), and materials about Epstein’s detention or death. It mandates the release of all such records unless specific, limited exceptions apply (e.g., to protect victims’ privacy, prevent child exploitation, or safeguard ongoing investigations). The resolution prohibits withholding documents solely due to embarrassment, reputational harm, or political sensitivity to officials or public figures. It also requires a detailed report to Congress within 15 days, listing all released materials, redactions, and unclassified summaries for any withheld classified information.
This bill (HR 4564) amends federal law to expand who can administer epinephrine in schools during emergencies. It replaces "school personnel" with "trained personnel" and allows non-employee volunteers (like parents or community members) to be treated as trained if they meet requirements and their state attorney general certifies the program. The bill also updates terminology from "auto-injectable epinephrine" to "epinephrine delivery systems" to include all administration methods. It directly affects schools, non-employee staff/volunteers, and state health authorities responsible for certification. The changes aim to make emergency allergy response more flexible while maintaining state oversight.
The Jobs in the Woods Act establishes a federal grant program to fund career training in forestry operations and products industries. It provides competitive grants (ranging from $500,000 to $2 million over up to 4 years) to eligible entities like nonprofits, states, tribes, or community colleges in targeted rural areas. These areas must be nonmetropolitan low-income communities, have broadband access, or have populations under 50,000. Grants require applicants to demonstrate regional need, plan for program sustainability, partner with schools, and address aging workforces or youth migration. The program is funded at $10 million annually from 2026 through 2030.
This bill requires the Environmental Protection Agency (EPA) to consult the National Academies of Sciences before finalizing new safety standards for fluoride in drinking water. Specifically, the EPA must arrange for the National Academies to conduct a rapid evidence review (within 90-180 days) of proposed fluoride rules, provide them all relevant data, and consider their findings. The bill affects federal regulators (the EPA) and the process for setting drinking water standards, not directly impacting the public or water systems. It does not change fluoride levels or safety thresholds but mandates an additional review step in rulemaking. The summary focuses solely on the procedural requirement added to the Safe Drinking Water Act.
HRES 588 is a non-binding House resolution condemning the slogan "Globalize the Intifada" as a call to violence against Israeli and Jewish people worldwide. It urges U.S. national, state, and local leaders to publicly denounce the slogan, which the resolution characterizes as undermining safety and security. The resolution cites historical context of violence during past intifadas and recent antisemitic incidents to support its position. As a symbolic measure, it has no legal effect but aims to encourage leaders to reject the slogan.
S 2316, the Cooper Davis and Devin Norring Act, requires electronic communication service providers and remote computing services to report to the Attorney General when they have actual knowledge of certain drug-related crimes involving fentanyl, methamphetamine, counterfeit prescription drugs, or unauthorized prescription medications. Providers must submit detailed reports within 60 days, including account information and relevant data about the crime, but not the content of communications. The bill imposes civil penalties of up to $190,000 for failing to report and $100,000 for submitting false reports, while protecting providers from being required to monitor content or scan for violations. It exempts broadband internet and text messaging service providers from these requirements and mandates annual reports from the Attorney General on the number and outcomes of submitted reports. The law aims to improve law enforcement's ability to address drug trafficking while maintaining privacy protections for users.
The Short on Competition Act creates a new process to address prescription drug shortages by allowing temporary imports of certain drugs. It permits the Secretary of Health and Human Services to authorize imports of drugs with the same active ingredient as a shortage drug, provided they are legally marketed in specific foreign countries and manufacturers commit to seeking U.S. approval. The bill also defines a "marginally competitive market" (fewer than five available drugs for two months, the drug approved over 10 years ago, and all patents expired) as triggering the importation process. Additionally, it requires annual reporting on the number of drugs approved for temporary importation.
